tiprankstipranks
Advertisement
Advertisement

INSM Stock Latest News

Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview
RatingsRitu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview
9d ago
INSM
Insmed initiated with an Outperform at BMO Capital
PremiumThe Fly
Insmed initiated with an Outperform at BMO Capital
10d ago
INSM
Insmed: TPIP’s Strong Durability and Risk‑Benefit Profile Support Buy Rating and Unchanged $212 Price Target
PremiumRatings
Insmed: TPIP’s Strong Durability and Risk‑Benefit Profile Support Buy Rating and Unchanged $212 Price Target
14d ago
INSM
Insmed Announces Positive 12-Month TPIP PAH Data
PremiumCompany Announcements
Insmed Announces Positive 12-Month TPIP PAH Data
14d ago
8K
INSM
Insmed Maintained at Buy as TPIP Data Underscore Long-Term Growth Potential and Justify Unchanged $214 Price Target
PremiumRatings
Insmed Maintained at Buy as TPIP Data Underscore Long-Term Growth Potential and Justify Unchanged $214 Price Target
14d ago
INSM
Matt Phipps Reiterates Buy on Insmed, Citing Strong TPIP PAH Data, Solid Brinsupri/Arikayce Growth, and Overdone Share Pullback
PremiumRatingsMatt Phipps Reiterates Buy on Insmed, Citing Strong TPIP PAH Data, Solid Brinsupri/Arikayce Growth, and Overdone Share Pullback
14d ago
INSM
Insmed’s inhalation powder shows efficacy and safety in arterial hypertension
Premium
The Fly
Insmed’s inhalation powder shows efficacy and safety in arterial hypertension
15d ago
INSM
Insmed price target raised to $161 from $160 at Wells Fargo
Premium
The Fly
Insmed price target raised to $161 from $160 at Wells Fargo
16d ago
INSM
Morgan Stanley Reaffirms Overweight on Brinsupri Launch Momentum, Keeps Price Target Unchanged at $212
PremiumRatings
Morgan Stanley Reaffirms Overweight on Brinsupri Launch Momentum, Keeps Price Target Unchanged at $212
24d ago
INSM
3 Healthcare Stocks with Strong Upside to Consider in July 2026, According to Analysts
PremiumMarket News
3 Healthcare Stocks with Strong Upside to Consider in July 2026, According to Analysts
27d ago
BSX
INSM
Blair adds American Express, Oracle to Conviction List in monthly update
PremiumThe Fly
Blair adds American Express, Oracle to Conviction List in monthly update
30d ago
P
CW
Ritu Baral Reiterates Buy on Insmed, Maintains $243 Price Target Amid Strong Respiratory Franchise Momentum and Improving Profitability Outlook
PremiumRatings
Ritu Baral Reiterates Buy on Insmed, Maintains $243 Price Target Amid Strong Respiratory Franchise Momentum and Improving Profitability Outlook
1M ago
INSM
Mizuho cuts Insmed target, sees buying opportunity after selloff
PremiumThe FlyMizuho cuts Insmed target, sees buying opportunity after selloff
2M ago
INSM
Midday Fly By: SpaceX IPO makes Elon Musk world’s first trillionaire
Premium
The Fly
Midday Fly By: SpaceX IPO makes Elon Musk world’s first trillionaire
2M ago
RH
RR
Nasdaq 100 Rebalancing Welcomes Five New AI and Space Stocks
Premium
Market News
Nasdaq 100 Rebalancing Welcomes Five New AI and Space Stocks
2M ago
ZS
DIA
Astera Labs, CoreWeave, Nebius, Rocket Lab, Teradyne added to Nasdaq-100
PremiumThe Fly
Astera Labs, CoreWeave, Nebius, Rocket Lab, Teradyne added to Nasdaq-100
2M ago
ZS
TER
Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step
PremiumCompany Announcements
Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step
2M ago
INSM
Insmed Advances Phase 3 Inhaled PAH Therapy, Keeping Growth Hopes Alive
PremiumCompany Announcements
Insmed Advances Phase 3 Inhaled PAH Therapy, Keeping Growth Hopes Alive
2M ago
INSM
Invesco QQQ Trust ETF (QQQ) Rebounds from Last Week’s Slump; What’s Fueling the Rise?
PremiumMarket News
Invesco QQQ Trust ETF (QQQ) Rebounds from Last Week’s Slump; What’s Fueling the Rise?
2M ago
ARM
NDX
Insmed stock price decline a ‘buying opportunity’, says Roth Capital
PremiumThe FlyInsmed stock price decline a ‘buying opportunity’, says Roth Capital
2M ago
INSM
Insmed price target lowered to $179 from $180 at JPMorgan
Premium
The Fly
Insmed price target lowered to $179 from $180 at JPMorgan
2M ago
INSM
Insmed price target lowered to $195 from $205 at RBC Capital
Premium
The Fly
Insmed price target lowered to $195 from $205 at RBC Capital
2M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >